izpis_h1_title_alt

An effective validation of analytical method for determination of a polar complexing agent : the illustrative case of cytotoxic bleomycin
ID Plešnik, Helena (Author), ID Omerzel, Maša (Author), ID Čemažar, Maja (Author), ID Serša, Gregor (Author), ID Kosjek, Tina (Author)

.pdfPDF - Presentation file, Download (1004,73 KB)
MD5: E3033F13BD19714C6D3937AD6B782121
URLURL - Source URL, Visit https://link.springer.com/article/10.1007/s00216-023-04675-x This link opens in a new window

Abstract
The effectiveness of highly polar agents in cancer treatment is well recognized, but their physicochemical properties make their analytical determination a demanding task. Their analysis requires peculiar sample preparation and chromatographic separation, which heavily impacts the precision of such an analytical method. As a case study, we chose a polar cytotoxic bleomycin, which is a mixture of complexing congeners with relatively high molecular mass, a fact that creates an added challenge in regard to its detection via electrospray mass spectrometry. These issues combined lead to a deprived method performance, so the aim of this study is manifold, i.e., to optimize, validate, and establish quality performance measures for determination of bleomycin in pharmaceutical and biological specimens. Quantification of bleomycin is done at diametrically different concentration levels: at the concentrations relevant for analysis of pharmaceutical dosage forms it is based on a direct reversed-phase HPLC-UV detection, involving minimum sample pretreatment. On the contrary, analysis of bleomycin in biological specimens requires phospholipid removal and protein precipitation followed by HILIC chromatography with MS/MS detection of bleomycin A2 and B2 copper complexes being the predominant species. This study further attempts to solve the traceability issue in the absence of certified reference standards, determines measurement uncertainty, investigates BLM stability and method performance characteristics, and, last but not least, provides an explanatory example of how a method quality assurance procedure should be established in case of an exceedingly complex analytical method.

Language:English
Keywords:liquid chromatography, mass spectrometry, biology, pharmaceutics, measurement uncertainty, stability
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
ZF - Faculty of Health Sciences
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:Str. 2737-2748
Numbering:Vol. 415, iss. 14
PID:20.500.12556/RUL-147543 This link opens in a new window
UDC:543
ISSN on article:1618-2650
DOI:10.1007/s00216-023-04675-x This link opens in a new window
COBISS.SI-ID:148531715 This link opens in a new window
Publication date in RUL:07.07.2023
Views:563
Downloads:82
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Analytical and bioanalytical chemistry
Shortened title:Anal. bioanal. chem.
Publisher:Springer Nature, GDCh, SFC, SEQA, RSEQ, DAS/SCS, ASAC, SCI, PTC
ISSN:1618-2650
COBISS.SI-ID:2520852 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:tekočinska kromatografija, masna spektrometrija, biologija, farmacija, merilna negotovost, stabilnost

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0143
Name:Kroženje snovi v okolju, snovna bilanca in modeliranje okoljskih procesov ter ocena tveganja

Funder:ARRS - Slovenian Research Agency
Project number:J1-6744
Name:Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bioanalitike

Funder:ARRS - Slovenian Research Agency
Project number:J4-2546
Name:Spremljanje kliničnega in imunskega odgovora za izboljšanje zdravljenja spontanih perifernih tumorjev psov s kombinacijo elektrokemoterapije in genskega elektroprenosa IL-12

Funder:ARRS - Slovenian Research Agency
Project number:J3-9269
Name:Klinično farmakološki pristop k optimizaciji terapevtske koncentracije bleomicina za zdravljenje z elektrokemoterapijo

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back